Experience with direct oral anticoagulants in pregnancy – a systematic review
- MedicineJournal of perinatal medicine
A meta-analysis displayed a higher rate of fetal loss and fetal abnormalities with DOACs use compared to LMWH, notwithstanding similar bleeding complications, and concluded thatDOACs can be safely used in pregnancy.
SHOWING 1-10 OF 13 REFERENCES
Is the use of direct oral anticoagulants safe during pregnancy?
- MedicineReproductive toxicology
Safety of direct oral anticoagulant exposure during pregnancy: a retrospective cohort study.
- MedicineThe Lancet. Haematology
Major bleeding risk associated with oral anticoagulant in real clinical practice. A multicentre 3‐year period population‐based prospective cohort study
- MedicineBritish journal of clinical pharmacology
The objective was to compare major bleeding risk of direct oral anticoagulants (DOACs; per type and dose) with vitamin K antagonists (VKAs), irrespective of indication, using real‐world data.
Apixaban therapy in a pregnant woman with heparin-induced thrombocytopenia and venous thromboembolic events caused by congenital antithrombin deficiency: A case report
- MedicineCase reports in women's health
Direct-Acting Oral Anticoagulants and Their Reversal Agents—An Update
A new generation of anticoagulants, the DOACs, and their reversal agents, are gaining prominence in clinical practice, having demonstrated superior efficacy and safety profiles and are poised to replace traditional anticoAGulants including warfarin.
EULAR recommendations for the management of antiphospholipid syndrome in adults
- MedicineAnnals of the rheumatic diseases
Evidence-based recommendations for the management of antiphospholipid syndrome (APS) in adults based on evidence from a systematic literature review and expert opinion were formulated and voted.
Oral anticoagulation with rivaroxaban during pregnancy: a case report.
- MedicineThrombosis and haemostasis
Examining the transplacental passage of apixaban using the dually perfused human placenta
- MedicineJournal of thrombosis and haemostasis : JTH
The objective was to determine the rate and extent of the placental transfer of apixaban, a novel oral anticoagulant that has not been studied in pregnant patients, and its effects on maternal andfetal levels.
Rivaroxaban transfer across the dually perfused isolated human placental cotyledon.
- BiologyAmerican journal of obstetrics and gynecology